Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03241589 · ClinicalTrials.gov registry record
Teledermatology Mobile App: Patient Facing
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 466
- Enrollment target
NCT03241589: Completed study, sponsored by VA Office of Research and Development.
NCT03241589 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 466 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03241589 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 466 participants
- Enrollment target
Study Summary
This study was designed to measure the impact of two teledermatology apps to provide direct to patient teledermatology follow up care, Patient Viewer and My VA Images, with a trial on access to dermatology care. The overall hypothesis was that sites implementing Department of Veterans Affairs' (VA) teledermatology mobile apps would significantly augment the use of teledermatology and improve Veterans' access to skin care relative to control sites. Specifically, the investigators hypothesized that these apps would improve established patients' ability to follow-up with dermatology care remotely, reducing patient travel to dermatology clinics while opening up dermatology clinic space for other patients. Due to a lack of participation by sites during the study which was conducted during the novel coronavirus (COVID-19) pandemic, the groups examined are Veterans who live in rural areas compared to those in urban areas. Previously the study included a parallel trial to evaluate another teledermatology mobile app, VA Telederm. This trial was no longer feasible within this study's funding timeline due to limitations imposed on the mobile app by Office of Information \& Technology that were not under the control of the PI or the operational partner, Office of Connected Care (OCC).
Interventions
- OTHER Direct to patient facing mobile apps introduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 466 participants |
| Start Date | 2019-05-13 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03241589
The ClinicalTrials.gov registry entry for NCT03241589 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 466 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Direct to patient facing mobile apps introduction is the first listed.
NCT03241589 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03241589 about?
NCT03241589 is a clinical study titled "Teledermatology Mobile App: Patient Facing". This study was designed to measure the impact of two teledermatology apps to provide direct to patient teledermatology follow up care, Patient Viewer and My VA Images, with a trial on access to dermatology care. The overall hypothesis was that sites implementing Department of Veterans Affairs' (VA) ...
What is the current status of trial NCT03241589?
This trial is currently completed. The enrollment target is 466 participants. The study started on 2019-05-13. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03241589?
The interventions under investigation include: Direct to patient facing mobile apps introduction (OTHER).
Who is sponsoring clinical trial NCT03241589?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.